Skip to main content

Table 4 The values of β, hazard ratio and P values in Cox multivariate regression model disease-free survival

From: Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study

  

β

Hazard ratio

P value

LR

Clinical T stage (3 vs. 4)

1.23

3.43

0.05

DFS

TRG score (3/4 vs. 1/2)

1.36

3.90

0.00

 

Clinical T stage (3 vs. 4)

1.11

3.04

0.01

  1. LR: local recurrence.
  2. DFS: disease-free survival.
  3. TRG: tumor regression grade.